|
[Related PubMed/MEDLINE] Total Number of Papers: 29
|
|
|
[Entries Per Page]
|
per page
|
|
Page Control
|
|
Page: of |
|
|
|
No. |
Year |
Title |
Co-occurring Abbreviation |
1 |
2022 |
Combined Therapy with Ixazomib, Lenalidomide, and Dexamethasone for Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome. |
ONLS, POEMS |
2 |
2019 |
"Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): Safety and efficacy of low-dose Iloprost, a prostacyclin analogue, in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arrest-syndrome patients." |
ENDO-RCA, OHCA, sTM, VE-cad |
3 |
2018 |
Raised VEGF: High sensitivity and specificity in the diagnosis of POEMS syndrome. |
COPD, NP, POEMS, VEGF |
4 |
2018 |
Serum Vascular Endothelial Growth Factor Levels in the IVAN Trial; Relationships with Drug, Dosing, and Systemic Serious Adverse Events. |
ATE, CI, HR, IME, nAMD, SSAEs |
5 |
2017 |
Synthetic microparticles conjugated with VEGF165 improve the survival of endothelial progenitor cells via microRNA-17 inhibition. |
OEPCs, VEGF, VEGF-MPs |
6 |
2016 |
Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest syndrome patients: study protocol for a randomized controlled trial. |
ENDO-RCA, OHCA, sTM, TEG |
7 |
2015 |
Are the high serum interleukin-6 and vascular endothelial growth factor levels useful prognostic markers in aggressive non-hodgkin lymphoma patients? |
IPI, NHL, SIL-6 |
8 |
2015 |
Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS). |
CATS, CI, SHR, VTE |
9 |
2012 |
High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy. |
DLBCL, PFS |
10 |
2012 |
Prognostic significance of vascular endothelial growth factor serum determination in women with ovarian cancer. |
--- |
11 |
2012 |
Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma. |
B2M, CR, DLBCL, IPI, LDH, NHL, OS, TTF |
12 |
2011 |
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias. |
TTR-A |
13 |
2010 |
Cotargeting of VEGFR-1 and -3 and angiopoietin receptor Tie2 reduces the growth of solid human ovarian cancer in mice. |
MRI |
14 |
2010 |
Phase II prospective trial of gefitinib given concurrently with cisplatin and radiotherapy in patients with locally advanced head and neck cancer. |
CRT, EGFR, HNSCC, RT |
15 |
2010 |
Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment. |
DMFS, NPC, OS |
16 |
2009 |
Serum vascular endothelial growth factor and angiogenesis are related to the prognosis of patients with gastrointestinal stromal tumors. |
GIST, HPF, MVD |
17 |
2006 |
[Effect of concurrent chemoradiotherapy on serum vascular endothelial growth factor in esophageal squamous cell carcinoma patients--a report of 43 cases]. |
ESCC |
18 |
2005 |
Bacterial antigen induced release of soluble vascular endothelial growth factor (VEGF) and VEGFR1 before and after surgery. |
VEGF |
19 |
2005 |
Influence of open versus laparoscopically assisted colectomy on soluble vascular endothelial growth factor (sVEGF) and its soluble receptor 1 (sVEGFR1). |
sVEGFR1 |
20 |
2005 |
[A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes]. |
MVD |
21 |
2004 |
[Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma]. |
CD44s, ELISA, MMP-3, NPC |
22 |
2003 |
Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. |
NHL, S-endostatin |
23 |
2003 |
Interferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinoma. |
IFN, RCC |
24 |
2003 |
[Effect of nedaplatin, 5-FU, and leucovorin combined with radiation therapy in unresectable esophageal carcinoma]. |
5-FU, LV, PD, PR |
25 |
2003 |
[Value of serum-vascular endothelial growth factor in the differential diagnosis of solitary pulmonary nodule]. |
SPN |
26 |
2002 |
Elevated serum vascular endothelial growth factor and decreased survival in advanced laryngeal carcinoma. |
ELISA |
27 |
2001 |
Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. |
ALL |
28 |
2001 |
The association between preoperative concentration of soluble vascular endothelial growth factor, perioperative blood transfusion, and survival in patients with primary colorectal cancer. |
--- |
29 |
2000 |
Serum vascular endothelial growth factor: a new predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. |
--- |
|